A different approach to the EGFR inhibitor Gefitinib involving solid-phase synthesis
André
Colorimetric assays
The colorimetric assays were performed based on reported procedures: DNP (2,4-dinitrophenylhydrazine) test to identify aldehydes and acetaldehyde/chloranil test to identify secondary amines.
Aldehydes monitoring assay 1
To prepare the DNP reagent solution, 2,4-dinitrophenylhydrazine (100 mg) was dissolved in concentrated H2SO4 (0.5 mL) followed by its slow addition to a mixture of H2O-EtOH (1:10, 7.7 mL). To apply this test, a few resin beads from the reaction were placed in a small test tube, with a small amount of DCM to allow the resin swelling. Then, 2-5 drops of DNP solution were added. After stirring at room temperature for a few minutes, the resin beads will turn red if the aldehyde groups are present.
Secondary amines monitoring assay 2
The 2% acetaldehyde and 2% chloranil (tetrachloro-1,4-benzoquinone) solutions were prepared in DMF. To apply this test, a few resin beads from the reaction were placed in a small test tube, and 2-5 drops of the 2% acetaldehyde solution was added followed by addition of the same amount of 2% chloranil solution. After 5 minutes under stirring at room temperature, the resin beads will turn green and after 30 minutes will become dark red, in the presence of secondary amine groups. To the previously vacuum-dried functionalized FMP-resin 5 (0.350 mmol) was added DMF (3 mL). Then, an aqueous solution of ammonia hydroxide 25% was added slowly (1 mL). The mixture was stirred at room temperature for 24 hours. The resin was washed with DMF:H2O (1:1) (4 mL x 10), THF (4 mL x 5) and DCM (4 mL x 5). The resin was dried under vacuum (500 mg, 99% over two steps, calculated based on weight).
max/cm -1 (KBr): 3436 (O-H stretch, broad), 1615 (m, C=C stretch); 1029 (s, C-F), 697 (s, C-Cl).
Removal from the resin by TFA treatment revealed the presence of 4-[3-chloro-4-fluoraniline]-6-hydroxy-7-methoxy quinazoline (6') (HPLC purity: >99%).
2.7 Synthesis of resin-bound 4-[3-chloro-4-fluoraniline]-7-methoxy-6-(-3-morpholin-4-ylpropoxy)
quinazoline (8) To the previously vacuum-dried functionalized FMP-resin 6 (500 mg, 0.347 mmol) was added dry DMSO.
Then,4-(3-chloropropyl)morpholine (7) (287 mg, 1.76 mmol) and NaOH (70 mg, 1.76 mmol) were added and the mixture was stirred at 85 o C for 72 hours. The resin was washed with DMF:H2O (1:1) (8 mL x 10), DMF (8 mL x 5), THF (8 mL x 5) and DCM (8 mL x 5). The resin was dried under vacuum (500 mg, 92 % calculated based on weight). (1) The general procedure to remove compounds from FMP-resin was performed to 400 mg (0.255 mmol) of functionalized FMP-resin 8. The obtained crude was resuspended in DCM and a NaOH 2 M solution was added to neutralize the removed compound. The organic phase was dried over Na2SO4 and evaporated to dryness.
Removal of Gefitinib
Gefitinib (1) 3 was obtained as a yellow solid (50 mg, 0.112 mmol, 44% of crude obtained from cleavage of resin-bound 8, HPLC purity: 99%) with an overall yield of 40 % (after five-step synthetic sequence). 
